These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 12063975

  • 1. Inhibition of Helicobacter pylori infection by orally administered yolk-derived anti-Helicobacter pylori antibody.
    Shimamoto C, Tokioka S, Hirata I, Tani H, Ohishi H, Katsu K.
    Hepatogastroenterology; 2002; 49(45):709-14. PubMed ID: 12063975
    [Abstract] [Full Text] [Related]

  • 2. Effect of dietary anti-urease immunoglobulin Y on Helicobacter pylori infection in Mongolian gerbils.
    Nomura S, Suzuki H, Masaoka T, Kurabayashi K, Ishii H, Kitajima M, Nomoto K, Hibi T.
    Helicobacter; 2005 Feb; 10(1):43-52. PubMed ID: 15691314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on Helicobacter pylori in humans.
    Horie K, Horie N, Abdou AM, Yang JO, Yun SS, Chun HN, Park CK, Kim M, Hatta H.
    J Dairy Sci; 2004 Dec; 87(12):4073-9. PubMed ID: 15545368
    [Abstract] [Full Text] [Related]

  • 5. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S, Hiratsuka T, Suzuki K, Kusunoki M, Wada K, Miyake K, Ohashi K, Shimizu M, Takahashi H, Gudis K, Kato S, Tsukui T, Sakamoto C.
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [Abstract] [Full Text] [Related]

  • 6. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection.
    Shin JH, Yang M, Nam SW, Kim JT, Myung NH, Bang WG, Roe IH.
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):1061-6. PubMed ID: 12204960
    [Abstract] [Full Text] [Related]

  • 7. Virulence factors of Helicobacter pylori affecting its gastric colonization in Mongolian gerbils.
    Iwao E, Hirayama F, Takagi S, Yokoyama Y, Ikeda Y.
    J Gastroenterol; 1999 Sep; 34 Suppl 11():47-54. PubMed ID: 10616766
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of a clinical isolate of urease-negative Helicobacter pylori and its ability to induce gastric ulcers in Mongolian gerbils.
    Mine T, Muraoka H, Saika T, Kobayashi I.
    Helicobacter; 2005 Apr; 10(2):125-31. PubMed ID: 15810942
    [Abstract] [Full Text] [Related]

  • 9. Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.
    Koizumi W, Tanabe S, Imaizumi H, Hibi K, Kida M, Ohida M, Okayasu I, Saigenji K.
    Hepatogastroenterology; 2003 Apr; 50(49):293-6. PubMed ID: 12630044
    [Abstract] [Full Text] [Related]

  • 10. Suppressive effect of rice extract on Helicobacter pylori infection in a Mongolian gerbil model.
    Murakami M, Ota H, Sugiyama A, Ishizone S, Maruta F, Akita N, Okimura Y, Kumagai T, Jo M, Tokuyama T.
    J Gastroenterol; 2005 May; 40(5):459-66. PubMed ID: 15942710
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
    Wu C, Shi Y, Guo H, Zou WY, Guo G, Xie QH, Mao XH, Tong WD, Zou QM.
    Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effect of anti-Helicobacter pylori urease immunoglobulin Y from egg yolk of immunized hens and Lactobacillus johnsonii No.1088 to inhibit the growth of Helicobacter pylori in vitro and in vivo.
    Aiba Y, Umeda K, Rahman S, Nguyen SV, Komatsu Y.
    Vaccine; 2019 May 21; 37(23):3106-3112. PubMed ID: 31031029
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B, Eck M, Greiner A, Lührs H, Vollmers HP, Müller-Hermelink HK.
    Virchows Arch; 2002 Aug 21; 441(2):143-7. PubMed ID: 12189503
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanism of action of low recurrence of gastritis caused by Helicobacter pylori with the type II urease B gene.
    Badruzzaman M, Matsui H, Fazle Akbar SM, Matsuura B, Onji M.
    Helicobacter; 2004 Apr 21; 9(2):173-80. PubMed ID: 15068420
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.
    Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T.
    Am J Gastroenterol; 2005 Jun 21; 100(6):1265-70. PubMed ID: 15929755
    [Abstract] [Full Text] [Related]

  • 20. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C, Triantafilou K, Rasche FM, Möricke A, Vogt K, Triantafilou M, Hahn P, Schneider EM, Lepper PM.
    Int J Med Microbiol; 2006 Aug 21; 296(4-5):223-8. PubMed ID: 16600680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.